Arzeda, The Industry-Leading Protein Design Company, Closes $33 Million Series B Funding Led By Conti Ventures
Amount Raised
$33 Million
Round Type
Series B
SeattleOtherBiotechnologyScience And EngineeringresearchDescription
Arzeda, the industry-leading Protein Design CompanyTM, announced today that it has closed a $33 million investment, in a Series B round of funding, led by Conti Ventures, the venture arm of investor Continental Grain Company. This round also includes investments from Lewis & Clark Agrifood, Bunge Ventures, the venture capital arm of the leading global agribusiness and food company Bunge, and Circulate Capital, among others, as well as repeat investments from Series A investors OS Fund, Casdin Capital, UMI and Bioeconomy Capital.
Quick answer
Arzeda raised $33 Million in a Series B round, dated March 30, 2022. Arzeda is based in Seattle, Washington, United States.
- How much did Arzeda raise?
- Arzeda raised $33 Million in a Series B round on March 30, 2022.
- What does Arzeda do?
- Arzeda, The Protein Design Company™, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability.
- Where is Arzeda based and how big is it?
- Arzeda is based in Seattle, Washington, United States. Fundz records about 64 employees.
- Who are the decision-makers at Arzeda?
- Fundz holds 2 contacts at Arzeda, including the COO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and research around the same time
Companies in the same sectors as Arzeda that raised within 45 days of this round, from Fundz verified event records.
- Moma Therapeutics raised $150M (Series B) on May 10, 2022.
- Sequentify raised $7M (Funding Round) on May 10, 2022.
- Aspen Neuroscience raised $375K (Seed) on May 10, 2022.
- Hemispherian AS raised an undisclosed amount (Seed) on May 3, 2022.
- Engimmune Therapeutics raised an undisclosed amount (Seed) on May 3, 2022.
- Haya Therapeutics raised an undisclosed amount (Funding Round) on May 3, 2022.
Who to call at Arzeda, and when
A new round usually means Arzeda is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Arzeda raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arzeda, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arzeda. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arzeda raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansArzeda raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.